Visikol Multiplex Technology and the Drug Discovery Process
Consumers across the world benefit from having access to the safest and most advanced drug discovery system. Every country [...]
Modern Approaches to Drug Discovery Panel
Visikol's Dr. Tom Villani, Ph.D. and Dr. Michael Johnson, Ph.D. participated in the 'Modern Approaches to Drug Discovery Panel' [...]
Updated Visikol Tissue Clearing Ebook Available
Over the holidays, the Visikol team had the opportunity to update the highly popular Tissue Clearing Ebook. If you [...]
The Broadest Liver In Vitro Model Portfolio in the Marketplace
Over the last several years, Visikol has worked to build out its liver cell culture capabilities from solely [...]
The Magic of BitSlide – Cloud-based Image Viewing and Sharing for Multiplex Data Sets
Carol Tomaszewski2022-01-05T11:08:12-05:00Multiplex tissue imaging provides the opportunity to generate large amounts of data from a single tissue for multiple [...]
Multiplex Cell Painting Assay for Pathological Diagnosis of Cells
Many human diseases are caused by morphological, physiological or genetic changes in cells. The challenges of disease diagnosis include [...]
How Many Markers are the Right Amount for Multiplex Tissue Imaging?
In the last few years, there has been an explosion in the number of platforms for multiplex tissue imaging [...]
One-step vs. two-step RT-PCR: Which should you choose?
RT-PCR, the laboratory technique that adds reverse transcription to the already game-changing polymerase chain reaction technology, can be overwhelming [...]
When Will Multiplex Tissue Imaging Start Being Used as a Clinical Tool?
The field of multiplex tissue imaging has been growing quickly over the last few years with a focus on [...]
Antibody Validation and the Visikol Multiplex Platform
In the 21st century, modern medicine has become more and more complex with an ever-growing need for researchers to [...]